Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Soft Tissue Leiomyosarcoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02131480
What this trial is testing

Study of Doxorubicin and Trabectedin in First Line Treatment on Patients With Metastatic Leiomyosarcoma

Who this might be right for
Uterus LeiomyosarcomaSoft Tissue Leiomyosarcoma
Gustave Roussy, Cancer Campus, Grand Paris 110
Early research (Phase 1)Study completedNCT00004123
What this trial is testing

Radiation Therapy Plus Doxorubicin in Treating Patients With Resectable Primary or Recurrent Retroperitoneal Soft Tissue Sarcoma

Who this might be right for
Sarcoma
M.D. Anderson Cancer Center 36
Not applicableUnknownNCT05548179
What this trial is testing

Exploring Clinical Trial Experiences of People With Leiomyosarcoma

Who this might be right for
Leiomyosarcoma
Power Life Sciences Inc. 500
Testing effectiveness (Phase 2)Ended earlyNCT04996004
What this trial is testing

Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With Leiomyosarcoma

Who this might be right for
Leiomyosarcoma
Pfizer 76
Not applicableUnknownNCT04214457
What this trial is testing

Development of a Predictive Model for Early Differential Diagnosis of Uterine Leiomyomas and Leiomyosarcomas

Who this might be right for
LeiomyomaLeiomyosarcoma
Igenomix 1,000
Early research (Phase 1)Ended earlyNCT06299163
What this trial is testing

NM32-2668 in Adult Patients With Selected Advanced Solid Tumors

Who this might be right for
Ovarian CarcinomaFallopian Tube CarcinomaPeritoneal Carcinoma+10 more
Numab Therapeutics AG 11
Testing effectiveness (Phase 2)Study completedNCT00887809
What this trial is testing

Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes

Who this might be right for
SarcomaLeiomyosarcomaMalignant Fibrous+2 more
Memorial Sloan Kettering Cancer Center 47
Early research (Phase 1)Study completedNCT00031681
What this trial is testing

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more
National Cancer Institute (NCI) 41
Post-approval studies (Phase 4)UnknownNCT00274885
What this trial is testing

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Who this might be right for
Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 58
Not applicableStudy completedNCT00897442
What this trial is testing

Collecting Tumor Samples From Patients With Gynecological Tumors

Who this might be right for
Borderline Ovarian Clear Cell TumorBorderline Ovarian Serous TumorCervical Adenocarcinoma+83 more
Gynecologic Oncology Group 275
Early research (Phase 1)Study completedNCT04242238
What this trial is testing

Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas

Who this might be right for
SarcomaAdvanced SarcomaHigh Grade Sarcoma+4 more
Memorial Sloan Kettering Cancer Center 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT05836571
What this trial is testing

Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue Sarcoma

Who this might be right for
Locally Advanced Extraskeletal Myxoid ChondrosarcomaLocally Advanced LeiomyosarcomaLocally Advanced Liposarcoma+7 more
National Cancer Institute LAO 66
Early research (Phase 1)Study completedNCT00062868
What this trial is testing

LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma

Who this might be right for
Hodgkin DiseaseNon Hodgkin LymphomaLymphoepithelioma+1 more
Baylor College of Medicine 74
Testing effectiveness (Phase 2)Study completedNCT00856050
What this trial is testing

Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma

Who this might be right for
Leiomyosarcoma
Dana-Farber Cancer Institute 27
Large-scale testing (Phase 3)UnknownNCT00334854
What this trial is testing

Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma

Who this might be right for
Childhood Malignant Fibrous Histiocytoma of BoneSarcoma
European Paediatric Soft Tissue Sarcoma Study Group 250
Testing effectiveness (Phase 2)Ended earlyNCT05116683
What this trial is testing

ATX-101 in Advanced Dedifferentiated Liposarcoma and Leiomyosarcoma

Who this might be right for
LeiomyosarcomaLiposarcoma
Benjamin Izar 4
Testing effectiveness (Phase 2)Study completedNCT00356031
What this trial is testing

Bevacizumab and Radiation Therapy for Sarcomas

Who this might be right for
Soft Tissue SarcomaFibrous HistiocytomaLiposarcoma+3 more
Massachusetts General Hospital 20
Early research (Phase 1)Study completedNCT01956084
What this trial is testing

Cytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma

Who this might be right for
Hodgkin DiseaseNon Hodgkin LymphomaLymphoepithelioma+2 more
Catherine Bollard 10
Testing effectiveness (Phase 2)Ended earlyNCT00003316
What this trial is testing

Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus

Who this might be right for
Sarcoma
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Study completedNCT03123276
What this trial is testing

Pembrolizumab and Gemcitabine Chemotherapy in Leiomyosarcoma and Undifferentiated Pleomorphic Sarcoma

Who this might be right for
Sarcoma
Royal Marsden NHS Foundation Trust 25
Next Page